期刊文献+

益气活血化痰法对气虚血瘀痰阻型医院获得性肺炎患者炎症因子、动脉血气及免疫功能的影响 被引量:7

Effect of Inflammatory Factors,Arterial Blood Gas and Immune Function on Yiqi Huoxue Huatan Therapy in the Treatment of Patients with Qi Deficiency and Phlegm and Blood Stasis Type Hospital Acquired Pneumonia
原文传递
导出
摘要 目的:探讨益气活血化痰法治疗气虚血瘀痰阻型医院获得性肺炎(HAP)患者的疗效及其对炎症因子、动脉血气和免疫功能的影响。方法:选取2017年1月到2018年1月在我院接受治疗的HAP患者84例,根据随机数字表法将患者分为对照组和观察组,两组均42例。对照组采用常规西医治疗,观察组在此基础上联用益气活血化痰法进行治疗。比较两组患者治疗前后的中医症状积分、急性生理与慢性健康评估II(APACHE II)、动脉血氧分压(PaO_2)、动脉二氧化碳分压(PaCO_2)、超敏C反应蛋白(hs-CRP)、肿瘤坏死因子-α(TNF-α)、白介素-6(IL-6)、降钙素原(PCT)、免疫球蛋白(Ig G、Ig M、Ig A)的水平,比较两组患者的不良反应。结果:治疗后两组患者的PaO_2水平明显升高,中医症状积分、APACHE II评分、PaCO_2、hs-CRP、TNF-α、IL-6、PCT水平明显降低(P<0.05),且治疗后观察组的PaO_2水平高于对照组,中医症状积分、APACHE II评分、PaCO_2、hs-CRP、TNF-α、IL-6、PCT水平低于对照组(P<0.05);治疗后观察组的IgG、IgM水平明显升高,且高于对照组(P<0.05),两组患者在治疗过程中均未出现明显的不良反应。结论:益气活血化痰法可有效治疗气虚血瘀痰阻型HAP患者,能明显改善患者的动脉血气、免疫功能和炎症反应,且无明显不良反应。 Objective: To explore the effect of Yiqi Huoxue Huatan therapy on the treatment of patients with Qi deficiency and phlegm and blood stasis type hospital acquired pneumonia(HAP) and its effect on inflammatory factors,arterial blood gas and immune function. Methods: 84 cases of HAP patients who were treated in our hospital from January 2017 to January 2018 were selected.The patients were divided into the control group and the observation group according to the random digital table method,and all the two groups were 42 cases. The control group using conventional western medicine treatment,the observation group on the basis of treatment with Yiqi Huoxue Huatan therapy. The scores of TCM symptom scores,acute physiology and chronic health evaluation II(APACHE II),arterial partial pressure of oxygen(PaO2),arterial partial pressure of carbon dioxide(PaCO2),hypersensitive C reactive protein(hs-CRP),tumor necrosis factor-α(TNF-α),interleukin 6(IL-6),procalcitonin(PCT),immunoglobulin(Ig G,Ig M,I g A)were compared before and after treatment of the two groups,the adverse reactions of the two groups were compared. Results: After treatment,the level of PaO2 in the two groups was significantly higher,and the TCM symptom scores,APACHE II scores,PaCO2,hs-CRP,TNF-α,IL-6 and PCT were significantly reduced(P〈0.05). After treatment,the level of PaO2 in the observation group was higher than that of the control group,the TCM symptom scores,the APACHE II score,PaCO2,hs-CRP,TNF-α,IL-6 and PCT were lower than those of the control group(P〈0.05). After treatment,the levels of Ig G and Ig M in the observation group increased significantly,which was higher than that in the control group(P〈0.05). No obvious adverse reactions were observed in the two groups during the treatment. Conclusion: Yiqi Huoxue Huatan therapy can effectively treat HAP patients due to deficiency of vital energy,blood stasis and phlegm type,which can significantly improve arterial blood gas,immune function and inflammatory factors,and has no obvious adverse reactions.
作者 王智 申太明 莫薇 兰燕 王乾梅 WANG Zhi;SHEN Tai-ming;MO Wei;LAN Yan;WANG Qian-mei(Department of Hospital Infection Management,Guilin Hospital Affiliated to Guangxi University of traditional Chinese Medicine,Guilin,Guangxi,541002,China;Department of Internal Medicine of Traditional Chinese Medicine,Guilin Hospital Affiliated to Guangxi University of traditional Chinese Medicine,Guilin,Guangxi,541002,China)
出处 《现代生物医学进展》 CAS 2018年第16期3102-3105,3110,共5页 Progress in Modern Biomedicine
基金 广西壮族自治区卫生厅基金项目(Z20134023)
关键词 医院获得性肺炎 益气活血化痰法 炎症因子 动脉血气 免疫功能 Hospital acquired pneumonia Yiqi Huoxue Huatan therapy Inflammatory factors Arterial blood gas Immune function
  • 相关文献

参考文献7

二级参考文献38

  • 1胡必杰,魏丽,张秀珍,唐英春,倪语星,黎毅敏,郭纪全,胡云建,张扣兴,杨莉.医院获得性肺炎发病时间对病原构成影响的回顾性队列研究[J].中华结核和呼吸杂志,2005,28(2):112-116. 被引量:48
  • 2汪光蓉,黄义山.ICU住院病人医院感染流行菌株及其耐药情况[J].世界感染杂志,2005,5(4):316-318. 被引量:12
  • 3沈自尹.中医虚证参考标准[J].中西医结合杂志,1986,6(10):598-598.
  • 4张爱荣.2002年至2005年临床分离的革兰氏阴性杆菌耐药监测研究及对策[J].中原医刊,2007,34(15):15-16. 被引量:1
  • 5American Thoracic Society, Infectious Diseases Society of Ameri- ca Guidelines for the management of adults with hospital - acqired, ventilator and heathcared - associated pheumonia [J]. American Jour- nal of Respiratory and Critical Care Medicine, 2005, 171 (4) : 388 -416.
  • 6National committee for clinical laboratory standards. Performance stand- ards for antimicrobial susceptibility testing; tenth inform ational supple- ment (aerobic dilution) [Z] . NCCLS, 2005: 100-514.
  • 7Soo Hoo GW, Wen YE, Nguyen TV, et al. Impact of clinical guide- lines in the management of severe hospital - acquired pneumonia [ J ]. Chest, 2005, 128:2778 -2787.
  • 8Murray CK, Hospenthal DR. Threatment of multidrug resistant Acine- obacter [J]. Curr Opin Infect Dis, 2005, 18 (6) : 502 -506.
  • 9Andriesse G1, Verhoef J. Nosocomial pneumonia; rationalizing the ap- proach to empirical therapy [ J ]. Treat Reapir Med, 2006, 5 ( 1 ) : 11 -30.
  • 10Ibrahim EH, Ward S, Sherman G, et al. A comparative analysis of pa- tients with early - onset vs late - onset nosocomial pneumonia in the ICU setting [J]. Chest, 2000, 117 (5): 1434-1442.

共引文献90

同被引文献141

引证文献7

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部